AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Fluid-responsiveness in Children Ventilated With LOW Tidal Volume - The FLOW Study.

RecruitingNAAges 0 Days - 15 YearsAllUniversity Hospital, Bordeaux
💬

In plain words

What the trial is, and whether it could suit you

In this study of diagnostic accuracy, the investigators aim to validate a fluid-responsiveness test in critically ill children mechanically ventilated with low tidal volume. This test is the famous respiratory variability of peak aortic velocity (ΔVPeak), which is based on cardiopulmonary interactions but is only validated in mechanically ventilated children with a tidal volume of at least 8ml/kg, which is uncommon nowadays. This would help physicians to identify children ventilated with low tidal volume and suffering from acute circulatory failure that could benefit from a volume expansion, thus avoiding a potentially useless or even dangerous fluid expansion that could lead to fluid overload. To this end, the diagnostic accuracy of ΔVPeak to predict fluid responsiveness (define as a 15% increase in echocardiographically measured SV after volume expansion) will be measured in mechanica

Sign in to get the eligibility rules as simple questions to take to your doctor.

📋 Eligibility rules (as published)
Inclusion Criteria: * Age between 0 days and 15 years old * Patient hospitalized in a pediatric intensive care unit. * Prescription of a 10ml/kg (±20%) fluid expansion by the physician in charge, as a standard care treatment of circulatory failure (precise indication is up to the physician in charge). * Mechanical ventilation * Tidal volume \< 6ml/kg (±15%) * Fluid responsiveness echocardiographic assessment as of routine care Exclusion Criteria: * Prematurity (corrected gestational age bellow 37 weeks) * Arythmia * Hemodynamic instability making dangerous the delay necessary for any measurement. * Prone position * Impairment of echocardiographic acoustic window * Extracorporeal membrane oxygenation * Respiratory rate (measured) \> 60 cycles per minute (including high frequency oscillation) * Significant breathing movements (high work of breathing, clinically assessed) * Restlessness with desynchronization patient/ventilator * Open chest * Cardiogenic pulmonary oedema * Known intracardiac or vascular shunt * Known hemodynamically significant valvopathy * Opposition to participate expressed by the patient or by a parent or legal guardian
💊

What it tests

  • Echocardiographic
📍

Where

6 sites
CHU d'Amiens Picardie
Amiens, France
CHU de BORDEAUX
Bordeaux, France
CHU de LIMOGES
Limoges, France
Hôpital Necker-Enfants Malades
Paris, France
Hôpital Robert Debré
Paris, France
CHU de Rouen Normandie
Rouen, France
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy